PERJETA and HER2+ breast cancer

See how PERJETA targets HER2 receptors in HER2+ breast cancer.

Financial assistance for patients

Genentech has multiple programs that may help your patients receive financial assistance.

Request more information

Genentech Clinical Oncology Specialists are available to answer your questions about PERJETA.